Capstone (CAPS) Competitors $1.82 -0.10 (-5.21%) As of 04/7/2025 03:59 PM Eastern Add Compare Share Share Competitors Stock AnalysisChartCompetitorsFinancialsSEC FilingsTrendsBuy This Stock CAPS vs. CWBR, BPTSY, MBIO, PTEIQ, EVFM, TRVN, NMTR, ERNA, TNFA, and WINTShould you be buying Capstone stock or one of its competitors? The main competitors of Capstone include CohBar (CWBR), Biophytis (BPTSY), Mustang Bio (MBIO), PolarityTE (PTEIQ), Evofem Biosciences (EVFM), Trevena (TRVN), 9 Meters Biopharma (NMTR), Eterna Therapeutics (ERNA), TNF Pharmaceuticals (TNFA), and Windtree Therapeutics (WINT). These companies are all part of the "pharmaceutical products" industry. Capstone vs. CohBar Biophytis Mustang Bio PolarityTE Evofem Biosciences Trevena 9 Meters Biopharma Eterna Therapeutics TNF Pharmaceuticals Windtree Therapeutics Capstone (NASDAQ:CAPS) and CohBar (NASDAQ:CWBR) are both small-cap manufacturing companies, but which is the superior stock? We will contrast the two companies based on the strength of their dividends, risk, earnings, profitability, valuation, analyst recommendations, institutional ownership, media sentiment and community ranking. Does the media favor CAPS or CWBR? In the previous week, Capstone's average media sentiment score of 0.00 equaled CohBar'saverage media sentiment score. Company Overall Sentiment Capstone Neutral CohBar Neutral Does the MarketBeat Community prefer CAPS or CWBR? CohBar received 18 more outperform votes than Capstone when rated by MarketBeat users. CompanyUnderperformOutperformCapstoneN/AN/ACohBarOutperform Votes1872.00% Underperform Votes728.00% Which has better valuation & earnings, CAPS or CWBR? Capstone has higher revenue and earnings than CohBar. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioCapstone$44.05M0.01N/AN/AN/ACohBarN/AN/A-$12.18MN/AN/A Which has more risk & volatility, CAPS or CWBR? Capstone has a beta of -0.79, suggesting that its share price is 179% less volatile than the S&P 500. Comparatively, CohBar has a beta of 1.39, suggesting that its share price is 39% more volatile than the S&P 500. Is CAPS or CWBR more profitable? Company Net Margins Return on Equity Return on Assets CapstoneN/A N/A N/A CohBar N/A N/A N/A Do insiders & institutionals have more ownership in CAPS or CWBR? 2.5% of Capstone shares are owned by institutional investors. Comparatively, 2.5% of CohBar shares are owned by institutional investors. 42.8% of Capstone shares are owned by company insiders. Comparatively, 6.5% of CohBar shares are owned by company insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a stock is poised for long-term growth. SummaryCapstone beats CohBar on 3 of the 5 factors compared between the two stocks. Remove Ads Get Capstone News Delivered to You Automatically Sign up to receive the latest news and ratings for CAPS and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart CAPS vs. The Competition Export to ExcelMetricCapstonePharmaceutical Preparations IndustryManufacturing SectorNASDAQ ExchangeMarket Cap$303,000.00$6.20B$1.94B$7.06BDividend YieldN/A2.87%2.76%4.17%P/E RatioN/A6.7723.1017.35Price / Sales0.01185.7258.4688.00Price / CashN/A65.67N/A34.64Price / BookN/A5.501.763.76Net IncomeN/A$141.14M-$389.14M$247.27M7 Day Performance-24.48%-10.19%-6.44%-6.63%1 Month PerformanceN/A-17.57%-8.65%-10.87%1 Year PerformanceN/A-19.66%-2.53%-8.39% Capstone Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)CAPSCapstoneN/A$1.82-5.2%N/AN/A$303,000.00$44.05M0.0038Gap DownCWBRCohBarN/A$0.41flatN/AN/A$1.19MN/A0.0010BPTSYBiophytisN/A$3.36flatN/AN/A$1.18MN/A0.0030MBIOMustang Bio1.7531 of 5 stars$1.22-6.2%$100.00+8,096.7%-96.5%$1.17MN/A-0.02100Gap DownPTEIQPolarityTEN/A$0.15flatN/A+704.4%$1.12M$810,000.00-0.0560EVFMEvofem Biosciences0.2127 of 5 stars$0.01+6.6%N/A-60.6%$1.10M$11.39M-0.02120High Trading VolumeTRVNTrevena0.8449 of 5 stars$1.20-1.6%$5.00+316.7%-88.3%$1.04M$443,000.00-0.0340Gap DownNMTR9 Meters BiopharmaN/AN/AN/AN/A$1.04MN/A-0.0220ERNAEterna Therapeutics0.4748 of 5 stars$0.19+4.5%N/A-91.5%$1.02M$582,000.00-0.0210TNFATNF PharmaceuticalsN/A$0.37-8.2%N/AN/A$1.02MN/A0.006Gap DownHigh Trading VolumeWINTWindtree Therapeutics1.7103 of 5 stars$1.30+5.7%$350.00+26,823.1%-99.7%$974,000.00N/A-0.0830Upcoming EarningsGap DownHigh Trading Volume Remove Ads Related Companies and Tools Related Companies CWBR Alternatives BPTSY Alternatives MBIO Alternatives PTEIQ Alternatives EVFM Alternatives TRVN Alternatives NMTR Alternatives ERNA Alternatives TNFA Alternatives WINT Alternatives Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:CAPS) was last updated on 4/8/2025 by MarketBeat.com Staff From Our PartnersFeds Just Admitted It—They Can Take Your CashThe Government Just Said Your Money Isn't Yours That's right—According to the DOJ, YOUR hard-earned money i...Priority Gold | Sponsored10X Bigger than AI, quantum, EVs, crypto, and robotics combined?World Economic Forum: "Arguably the Most Exciting Human Discovery Since Fire" Sam Altman, Bill Gates, and M...Stansberry Research | SponsoredThree new patents reveal Elon and Trump’s secret “Project America”Right now for a limited time… You can get Tim Bohen’s top 5 Trump stocks for 2025… For only ONE DOLLAR!...Timothy Sykes | SponsoredWarning: “DOGE Collapse” imminentElon Strikes Back You may already sense that the tide is turning against Elon Musk and DOGE. Just this week...Altimetry | SponsoredTrump’s Secret WeaponHave you looked at the stock market recently? Millions of investors are scrambling trying to figure out what's...American Alternative | SponsoredTrump’s betrayal exposed Trump’s Final Reset Inside the shocking plot to re-engineer America’s financial system…and why you need to ...Porter & Company | SponsoredYour Retirement Is Caught in the CrossfireWhen Trump took office in 2017, gold was just $1,100 an ounce. By the time he left, it had soared to $1,839. ...Premier Gold Co | SponsoredGold Hits $3,000… Here’s How You Can Get More for Under $20With gold surging to record highs, currently trading above $3,000 an ounce, and central banks aggressively sto...The Oxford Club | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Capstone Holding Corp. Please log in to your account or sign up in order to add this asset to your watchlist. Share Capstone With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Buy CAPS Stock Free CAPS Stock Alerts